title: Safe and effective treatment of aggressive non-hodgkin lymphoma with rituximab and bendamustine in patients with severe liver impairment.
authors.affiliation: Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC 20007-1229, USA. km103@gunet.georgetown.net
authors.forename: James K
authors.initials: JK
authors.lastname: McCloskey
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Broome
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Cheson
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000150:complications*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D009588:Nitrogen Mustard Compounds; D000069283:Rituximab; D000069461:Bendamustine Hydrochloride